Working together to reduce the global burden of kidney cancer
Kidney cancer is a global issue. Every year, 431,000 people worldwide will be diagnosed with kidney cancer.

Click here for shareable information, graphics and materials about kidney cancer for patient organisations worldwide.

Executive Leadership Changes at IKCC
The IKCC Board of Directors has announced three exciting upcoming executive leadership changes.
Dr Eric Jonasch (US) has accepted the role of Board Chair of IKCC’s Board of Directors, Claudia Ungarelli (IT) will be moving into the role of Vice-Chair and Prof. Stênio de Cássio Zequi (BR) will take on the position of Chair of the IKCC Medical Advisory Board.

World Kidney Cancer Day 2025 – 19 June
Save the date: The next World Kidney Cancer Day will be on Thursday 19th June 2025. It is celebrated around the world every year on the third Thursday of June by patients, carers, healthcare professionals and local organisations.
Show your kidneys some love is the theme for the 2025 campaign. Based on findings from the recent Global Patient Survey, we will be focusing on raising awareness of the importance of kidney health when affected by kidney cancer.

Summary of Kidney Cancer Highlights from ASCO GU 2025
This year’s American Society of Clinical Oncology Genitourinary Cancers (ASCO GU) Symposium was held from 13-15 February 2025, in San Francisco, California, USA. Some affiliates of the International Kidney Cancer Coalition (IKCC) went to the meeting to keep up to date with the care and treatment of patients with kidney cancer and have created a patient-friendly summary of highlights related to kidney cancer treatment. A brief ‘Take home messages’ section is followed by more in-depth review of selected abstracts.
Did you know?
Kidney cancer is often found by accident.
Kidney cancer is the 14th most prevalent cancer worldwide.
About 59 per cent of kidney cancer cases occur in more developed countries.
Join our mailing list
In the newsletter we highlight news about kidney cancer diagnosis and treatment, and other relevant discussions.